Health Catalyst, Inc.
HCAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $76 | $81 | $79 | $80 |
| % Growth | -5.4% | 1.6% | -0.2% | – |
| Cost of Goods Sold | $39 | $42 | $43 | $45 |
| Gross Profit | $38 | $38 | $36 | $35 |
| % Margin | 49.5% | 47.4% | 45.6% | 43.6% |
| R&D Expenses | $12 | $12 | $15 | $15 |
| G&A Expenses | $16 | $8 | $14 | $16 |
| SG&A Expenses | $30 | $21 | $29 | $27 |
| Sales & Mktg Exp. | $14 | $13 | $15 | $11 |
| Other Operating Expenses | $13 | $41 | $12 | $10 |
| Operating Expenses | $55 | $75 | $56 | $52 |
| Operating Income | -$18 | -$37 | -$20 | -$18 |
| % Margin | -22.9% | -46% | -25.4% | -22% |
| Other Income/Exp. Net | -$5 | -$4 | -$3 | -$3 |
| Pre-Tax Income | -$22 | -$41 | -$24 | -$20 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | -$22 | -$41 | -$24 | -$21 |
| % Margin | -29.1% | -50.8% | -29.9% | -26% |
| EPS | -0.32 | -0.59 | -0.35 | -0.33 |
| % Growth | 45.8% | -68.6% | -6.1% | – |
| EPS Diluted | -0.32 | -0.59 | -0.35 | -0.33 |
| Weighted Avg Shares Out | 70 | 70 | 69 | 62 |
| Weighted Avg Shares Out Dil | 70 | 70 | 69 | 62 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $4 | $5 |
| Interest Expense | $6 | $6 | $7 | $7 |
| Depreciation & Amortization | $13 | $13 | $12 | $10 |
| EBITDA | -$4 | -$22 | -$4 | -$2 |
| % Margin | -5.2% | -27.8% | -4.9% | -3.1% |